Dogs
Every published study in dogs held in the database.
This page lists published studies. It reports what the authors did and found, with the limits of each study. It is not advice.
16 studies listed, newest first.
- Levagen+ (palmitoylethanolamide) alleviates joint pain and reduces the impact of joint pain in canines and felines: a double-blind, placebo-controlled, randomized clinical trialRandomised controlled trialDogsCats
- Palmitoylethanolamide in Human and Animal ObesityReviewHumansDogsCats
- Palmitoylethanolamide and Related ALIAmides for Small Animal Health: State of the ArtReviewDogsCats
- Circulating Endocannabinoids in Canine Multicentric Lymphoma PatientsObservational studyDogs
- Chronic Pain in Dogs and Cats: Is There Place for Dietary Intervention with Micro-Palmitoylethanolamide?ReviewDogsCats
- Chronic Pain in Dogs and Cats: Is There Place for Dietary Intervention with Micro-Palmitoylethanolamide?ReviewDogsCats
- Successful and Unsuccessful Brain Aging in Pets: Pathophysiological Mechanisms behind Clinical Signs and Potential Benefits from Palmitoylethanolamide Nutritional InterventionReviewDogsCats
- Localization of cannabinoid receptors CB1, CB2, GPR55, and PPAR-alpha in the canine gastrointestinal tractLaboratory studyDogs
- Ultramicronized palmitoylethanolamide counteracts the effects of compound 48/80 in a canine skin organ culture modelLaboratory studyDogs
- The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channelsLaboratory studyHumansDogsOther animals
- Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitisLaboratory studyDogsOther animals
- Efficacy of ultra-micronized palmitoylethanolamide in canine atopic dermatitis: an open-label multi-centre studyOpen-label, no control groupDogs
- Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitisLaboratory studyDogs
- Effects of palmitoylethanolamide on the cutaneous allergic inflammatory response in Ascaris hypersensitive Beagle dogsLaboratory studyDogs
- Inhibitory effect of topical adelmidrol on antigen-induced skin wheal and mast cell behavior in a canine model of allergic dermatitisControlled trialDogsTopicalWith adelmidrol (a PEA analogue, tested alone)
- Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNF-alpha release from canine skin mast cellsLaboratory studyDogs